Trial
NCT05399368
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
RAPT Therapeutics, Inc.
Collaborators
—
Condition
Atopic Dermatitis
Intervention
RPT193
Why stopped
Study on clinical hold by FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-23